Bio-Rad Laboratories, Inc. (BIO)
NYSE·Healthcare·Medical - Devices
$281.54
-2.00%
Mkt Cap $8.12B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 12, 2026 | $688.81M | $693.20M | +0.64% | $2.57 | $2.51 | -2.33% | — | — |
| Q4 2025 Oct 29, 2025 | $694.64M | $653.00M | -5.99% | $2.30 | $2.26 | -1.74% | — | — |
| Q3 2025 Jul 31, 2025 | $633.81M | $651.60M | +2.81% | $1.93 | $2.61 | +35.23% | — | — |
| Q2 2025 May 1, 2025 | $573.23M | $585.40M | +2.12% | $1.73 | $2.54 | +46.82% | — | — |
| Q1 2025 Feb 13, 2025 | $679.75M | $667.48M | -1.81% | $2.86 | $2.90 | +1.40% | — | — |
| Q4 2024 Oct 30, 2024 | $681.29M | $649.73M | -4.63% | $1.28 | $2.01 | +57.03% | — | — |
| Q3 2024 Aug 1, 2024 | $645.79M | $638.48M | -1.13% | $2.12 | $3.11 | +46.70% | — | — |
| Q2 2024 May 7, 2024 | $619.09M | $610.82M | -1.34% | $2.15 | $2.29 | +6.51% | — | — |
| Q1 2024 Feb 15, 2024 | $685.09M | $681.18M | -0.57% | $2.93 | $3.10 | +5.80% | — | — |
| Q4 2023 Oct 26, 2023 | $689.57M | $632.12M | -8.33% | $2.87 | $2.33 | -18.82% | — | — |
| Q3 2023 Aug 3, 2023 | $697.96M | $681.11M | -2.41% | $2.55 | $3.00 | +17.65% | — | — |
| Q2 2023 May 4, 2023 | $689.83M | $676.84M | -1.88% | $3.24 | $3.34 | +3.09% | — | — |
| Q1 2023 Feb 16, 2023 | $742.26M | $730.29M | -1.61% | $3.45 | $3.31 | -4.06% | — | — |
| Q4 2022 Oct 27, 2022 | $679.94M | $680.80M | +0.13% | $2.59 | $2.60 | +0.39% | — | — |
| Q3 2022 Jul 28, 2022 | $682.62M | $691.10M | +1.24% | $2.46 | $3.38 | +37.40% | — | — |
| Q2 2022 Apr 28, 2022 | $672.63M | $700.06M | +4.08% | $2.80 | $4.94 | +76.43% | — | — |
| Q1 2022 Feb 10, 2022 | $730.26M | $732.77M | +0.34% | $2.87 | $3.21 | +11.85% | — | — |
| Q4 2021 Oct 28, 2021 | $661.87M | $747.05M | +12.87% | $2.30 | $3.71 | +61.30% | — | — |
| Q3 2021 Jul 29, 2021 | $545.57M | $715.93M | +31.23% | $1.90 | $3.54 | +86.32% | — | — |
| Q2 2021 Apr 29, 2021 | $710.53M | $726.80M | +2.29% | $2.50 | $5.21 | +108.40% | — | — |